Consistent with this notion, PAR1 downregulation activated the Hippo pathway and inhibited YAP and TAZ expression, indicating the critical role of PAR1 in suppressing the Hippo pathway and thus triggering YAP/TAZ activation in invasive breast cancer cells. This evidence concerns the gene F2R and breast cancer.